METHOD FOR PREDICTION OF SYNCHRONOUS MULTIFOCAL COLORECTAL CARCINOMA Russian patent published in 2015 - IPC G01N33/44 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to oncology, and can be used for recognising synchronous multifocal colorectal carcinoma. Substance of the invention consists in measuring preoperative blood follicle-stimulating hormone both in male and female patients suffering from colorectal carcinoma. If its concentration falls within the range of 26.01 to 60.91 IU/l in the females and of 2.71 to 5.67 IU/ml in the males, a single tumour is diagnosed in the patients, and if the hormone concentration is from 2.70 to 5.50 IU/ml in the females and from 12.88 to 52.04 IU/l in the males, the presence of synchronous colorectal new growths are stated. The method can be implemented at the preoperative stage; it is easily reproducible in the oncology hospital environment.

EFFECT: stating the presence of synchronous multifocal colorectal carcinoma.

6 ex